File Name: streptozotocin induced diabetic models in mice and rats .zip
Animal models have historically played a critical role in the exploration and characterization of disease pathophysiology and target identification and in the evaluation of novel therapeutic agents and treatments in vivo. Diabetes mellitus disease, commonly known as diabetes, is a group of metabolic disorders characterized by high blood glucose levels for a prolonged time. To avoid late complications of diabetes and related costs, primary prevention and early treatment are therefore necessary.
- Improving the Reliability and Utility of Streptozotocin-Induced Rat Diabetic Model
- Streptozotocin‐Induced Diabetic Models in Mice and Rats
- Experimental Diabetes Mellitus in Different Animal Models
Improving the Reliability and Utility of Streptozotocin-Induced Rat Diabetic Model
Diabetes is a disease characterized by a relative or absolute lack of insulin, leading to hyperglycaemia. There are two main types of diabetes: type 1 diabetes and type 2 diabetes. Type 1 diabetes is due to an autoimmune destruction of the insulin-producing pancreatic beta cells, and type 2 diabetes is caused by insulin resistance coupled by a failure of the beta cell to compensate. Animal models for type 1 diabetes range from animals with spontaneously developing autoimmune diabetes to chemical ablation of the pancreatic beta cells. Type 2 diabetes is modelled in both obese and non-obese animal models with varying degrees of insulin resistance and beta cell failure. This review outlines some of the models currently used in diabetes research.
Streptozotocin‐Induced Diabetic Models in Mice and Rats
Department of Therapeutics, Chromocell Corporation, U. Regarding the data availability, all data used to support the findings of this study are included within the article. The Streptozotocin- STZ- induced diabetic model is widely used; however, unexplained acute toxicity has given the model an unreliable reputation. To improve the reliability and utility of this model, we characterize the age dependence of STZ toxicity and introduce novel endpoints to assess diabetic complications and reveal possible mechanisms for diabetic development. Their metabolic glucose, lipids, and hormones , inflammatory cytokines , histologic and behavioral endpoints were observed for 1.
Skip to search form Skip to main content You are currently offline. Some features of the site may not work correctly. DOI: Also described are protocols for creating animal models for type 2 diabetes using STZ. View on Wiley.
Streptozotocin (STZ) is an antibiotic that can cause pancreatic β-cell destruction, so it is widely used experimentally as an agent capable of inducing insulin-.
Experimental Diabetes Mellitus in Different Animal Models
Mice were monitored for 30 d for adverse side effects, blood glucose, and insulin requirements. Rodent models commonly are used to study immunologic mechanisms and metabolic function in diabetes. We use congenitally athymic nude mice to avoid any interference of immune rejection on the outcome of results.
This is an open access article distributed under the terms of Creative Commons Attribution License. Diabetes mellitus DM is a metabolic disease characterized by abnormal glucose metabolism 1. The disease can cause a number of complications that affect the quality of life of patients 2 , 3.
To View More...
Pamela M. Martin, Penny Roon, Tracy K. Neuronal cell death has been reported in retinas of humans with diabetic retinopathy and in diabetic rat models.
Metrics details. The aim of the present study was to investigate the effects of ginger on various tissues i. The pleasant aroma of ginger comes from the constituents present in its volatile oil, while its non-volatile pungent phytochemicals consist of gingerols, shogaols, and paradols. This research was conducted to determine the effects of 6-shogaol administration on blood glucose and insulin production in type 1 diabetic mice. Since, 6-shogaol prevented the damage for STZ induced stress.